Experience of Epoprostenol Infusion in Patients With Right Heart Failure Secondary to Pulmonary Hypertension

Abstract

PURPOSE: To describe the clinical characteristics of patients undergoing to Epoprostenol therapy for the treatment of right heart failure secondary to pulmonary hypertension. METHODS: Retrospective cohort of patients admitted to the emergency room because of right heart failure secondary to pulmonary hypertension between jan 2011 to oct 2015. Adults older than 18 y with epoprostenol infusión during the index hospitalization where included. Data were extracted from the pulmonary hypertension registry (SHIP) of a high complexity institution in Cali, Colombia.